Introduction to Intragastric Balloon
Intragastric balloon is a medical device which is placed in the stomach for the treatment of obesity when diet and exercise fail to function for an individual. It is a saline or gas-filled balloon which is inserted through an endoscopic procedure into the stomach of an individual. Since it is placed in the stomach, it confines the amount of food that stomach can hold, thereby providing an early feeling of satiety. Feeling of fullness by the placement of balloon can also be attributed to the changes in levels of hormones that control the appetite. This device can be used by individuals having body mass index (BMI) between 30-40 kg/m2. It should not be implanted into an individual if there has been any previous esophageal, stomach or intestinal surgery. Individuals with intestinal problems such as, inflammatory bowel disease or delayed gastric emptying, pregnant women and those who consume nonsteroidal anti-inflammatory drug (NSAID) such as, aspirin regularly are also advised not to undergo intragastric balloon surgery. The device is removed after the six months of insertion by endoscopy again.
Market Size and Forecast
The market is observing a robust growth on the back of notable features of intragastric balloon in decreasing the risk of cardiovascular diseases and high blood pressure. Additionally, reducing the chances of occurrence of sleep apnea and type 2 diabetes are also anticipated to propel the growth of the market. Moreover, sedentary lifestyle is among the major reasons behind the growing number of incidences of obesity which is projected to drive the growth of the market and lead to the adoption of the device.
The global intragastric balloon market is anticipated to record a CAGR of around 18% over the forecast period i.e. 2019-2027. The market is segmented by product type into single, dual and triple intragastric balloon, out of which, triple intragastric balloon segment is anticipated to have a higher demand in the global intragastric balloon market throughout the forecast period owing to increase in patient comfort, tolerability and progressive weight loss.
Get more information on this report: Download Sample PDF
Growth Drivers
Minimally Invasive Technique
The intragastric balloon is implanted through a 30-minute minimally invasive endoscopic procedure while the patient is under a mild anesthesia. Since the procedure is less time consuming and performed without any incision, it is projected to positively impact the growth of the market.
Safe and Cost Effective
The procedure ensures safety and effective weight management with rare chances of side effects. This can be attributed to the increased commercial availability of the product and the advantage of providing safety through blue dye in urine that will alert the patient, in case the balloon ruptures. Additionally, the procedure is less expensive as compared to other surgical methods. These factors are estimated to significantly support the growth of the market over the forecast period.
Restraints
Side Effects Associated with Intragastric Balloons
Side effects associated with intragastric balloons such as, nausea, pain, vomiting, stomach cramps, reflux along with indigestion, flatulence, bloating and diarrhea are estimated to hinder the growth of the market. Additionally, rare side effects such as esophagitis, gastric ulcer formation, gastric perforation owing to the damage of tissue wall and leakage of balloon can lead to its migration to other tissue which ultimately triggers the intestinal obstruction are among other restraining factors that are anticipated to dampen the growth of the market.
Market Segmentation
Our-in depth analysis of the global intragastric balloon market includes the following segments:
By Product Type
- Single Intragastric Balloon
- Dual Intragastric Balloon
- Triple Intragastric Balloon
By Filling Material
- Saline-Filled
- Gas-Filled
By End-User
- Outpatient Surgery Centers
- Hospitals
- Clinics
By Region
On the basis of regional analysis, the global intragastric balloon market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
The market in North America region is anticipated to show a significant growth over the forecast period followed by Asia Pacific. This can be attributed to high prevalence of obesity in these regions. According to OECD, the United States has the highest rate of obesity which contributes to approximately 100000-400000 deaths on an annual basis in the country. These factors are estimated to boost the growth of the market in North America region.
The global intragastric balloon market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating the Market
- Allurion Technologies
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Apollo Endosurgery
- Obalon Therapeutics
- Spatz3
- ReShape Medical
- Silimed
- Lexel
- Districlass Medical
- Other Prominent Players
